Allan-Blitz is a pediatrician and adult medicine specialist. Klausner is a professor of population and public health sciences ...

Cancer clinical trials lack diversity, with white patients overrepresented and minorities, women, and the elderly ...

Instead of reaching for a pill, more people should switch to the recommended "first line" treatment for insomnia—the non-drug ...

Since the pandemic, drug trials that purposely make people vomit, shiver and ache have become a research area of growing ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Yes—but at a slightly smaller dose than teens and adults. Children who are 2 weeks to 12 years old take a twice-daily dose ...

As a result of the new administration's actions, health centers funded by PEPFAR, the U.S. President's Emergency Plan for ...